Effects of dantrolene sodium on intracellular Ca2+handling in normal and Ca2+-overloaded cardiac muscle

European Journal of Pharmacology

Volumn 316, Issue 2-3, 1996, Pages 333-342

  Meissner, Achim ^a   Szymanska, Grazyna ^b   Morgan, James P ^b  

^a UNIVERSITY OF KIEL   (Germany)

^b BETH ISRAEL DEACONESS MEDICAL CENTER   (United States)

Author keywords

Aequorin; Ca2+; Ca2+ indicators; Dantrolene; Myocardium; Sarcoplasmic reticulum

Indexed keywords

DANTROLENE;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; CALCIUM HOMEOSTASIS; CONTROLLED STUDY; HEART MUSCLE CELL; IN VITRO STUDY; INOTROPISM; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; SARCOPLASMIC RETICULUM;

ANIMALS; CALCIUM; DANTROLENE; DOSE-RESPONSE RELATIONSHIP, DRUG; HEART; ISOMETRIC CONTRACTION; MALE; RATS; RATS, WISTAR;

EID: 0030571492     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0014-2999(96)00678-4     Document Type: Article

References (40)

1. Allen, D.G., D.A. Eisner, J.S. Pirolo and G.L. Smith, 1985, The relationship between intracellular calcium and contraction in calcium-overloaded ferret papillary muscles, J. Physiol. 364, 169.
2. Beuckelmann, D.J., M. Nabauer and E. Erdmann, 1992, Intracellular calcium handling in isolated ventricular myocytes from patients with terminal heart failure, Circulation 85, 1046.
3. Brocklehurst, L., 1975, Dantrolene sodium in skinned muscle fibres. Nature 254, 364.
4. Blinks, J.R., 1982, The use of photoproteins as calcium indicators in cellular physiology, in: Techniques in Cellular Physiology, Part III., ed. P.F. Baker (Elsevier/North Holland Science, Shannon) pp. 126/1-126/38.
5. Brooks, R.R., J.F. Carpenter, S.M. Jones and C.M. Gregory, 1989, Effects of dantrolene sodium in a rodent model of cardiac arrhythmia, Eur. J. Pharmacol. 164, 521.
6. Clusin, W.T., M. Buchbinder and D.C. Harrison, 1983, Calcium overload, 'injury' current and early ischaemic cardiac arrhythmias: a direct connection, Lancet i, 272.
7. 2+ and depolarization, Biochim. Biophys. Acta 816, 18.
8. Davidenko, J., M. Delmar, R. Oates and J. Jalife, 1986, Electrophysiological actions of dantrolene sodium in isolated sinoatrial and atrioventricular nodes and in a model of ischemia, J. Pharmacol. Exp. Ther. 23, 206.
9. Ellis, F.R., J.J. Heffron, 1985, Clinical and biochemical aspects of malignant hyperthermia, in: Recent Advances in Anesthesia and Analgesia, ed. R.S. Atkinson and A.P. Adams (Churchill-Livingstone, New York, NY), pp. 173-207.
10. Feher, J.J., N.H. Manson and J.L. Poland, 1988, The rate and capacity of calcium uptake by sarcoplasmic reticulum in fast, slow and cardiac muscle: Effects of ryanodine and ruthenium red, Arch. Biochem. Biophys. 265, 171.
11. 2+ handling in myocardium from patients with endstage heart failure, Circ. Res. 61, 70.
12. Honerjaeger, P. and N. Alischewski, 1983, Inotropic and electrophysiologic effects of dantrolene on guinea pig papillary muscle, Naunyn-Schmiedeberg's Arch. Pharmacol. 322, 237.
13. January, C.T. and H.A. Fozzard, 1988, Delayed afterdepolarizations in heart muscle: mechanisms and relevance, Pharmacol. Rev. 40, 219.
14. Kentsch, M., N. Roewer, K.P. Kunze and K.H. Kuck, 1991, Intravenous dantrolene does not exhibit calcium channel blocking effects on the cardiac conduction system in humans, Anaesthesiology 75, 583.
15. 2+ transients during hypoxia, ischemia and reperfusion of the intact mammalian heart, Circ. Res. 65, 1029.
16. Kihara, Y. and J.P. Morgan, 1989, A comparative study of three methods for intracellular loading of the calcium indicator aequorin in ferret papillary muscles, Biochem. Biophys. Res. Commun. 162, 402.
17. Kihara, Y. and J.P. Morgan, 1991, Intracellular calcium and ventricular fibrillation: studies in the aequorin-loaded isovolumic ferret heart, Circ. Res. 68, 1378.
18. Kranias, E.G. and R.J. Solaro, 1982, Phosphorylation of troponin I and phospholamban during catecholamine stimulation of rabbit heart, Nature 298, 182.
19. Krause, S.M., W.E. Jacobus and L.C. Becker, 1989, Alterations in cardiac sarcoplasmic reticulum calcium transport in the post-ischemic 'stunned' myocardium, Circ. Res. 65, 526.
20. Lakatta, E.G., 1989, Chaotic behavior of myocardial cells: possible implications regarding the pathophysiology of heart failure, Perspect. Biol. Med. 32, 241.
21. 2+] measured in vivo in patients susceptible to malignant hyperthermia, Anesthesiology 76, 711.
22. Lowry, O.H., N.J. Rosebrough, A.L. Farr and R.J. Randall, 1951, Protein measurement with the Folin phenol reagent, J. Biol. Chem. 193, 165.
23. Martell, A.E. and R.M. Smith, 1974, Critical stability constants, Vol. 1B, Tertiary amines (Plenum Press, New York, NY) pp. 269-272.
24. 2+ by sarcoplasmic reticulum fragments, J. Biol. Chem. 239, 648.
25. 2+ modulation in the coronary perfused rat heart during post-ischemic reperfusion, Am. J. Physiol. 268, H100.
26. Mitchell, M.B., C.B. Winter, A. Banerjee and A.H. Harken, 1993, Inhibition of sarco-plasmic reticulum calcium release reduces myocardial stunning, J. Surg. Res. 54, 411.
27. Morgan, J.P., R.E. Erny, P.D. Allen, W. Grossmann and J.K. Gwathmey, 1990, Abnormal intracellular calcium handling, a major cause of systolic and diastolic dysfunction in ventricular myocardium from patients with heart failure, Circulation 88 (Suppl. III), III-21.
28. 2+ release from sarcoplasmic reticulum in guinea pig skeletal muscle, Eur. J. Pharmacol. 178, 11.
29. 2+ ion concentration by metal chelators, in: Methods in Pharmacology, ed. A. Schwartz (Plenum Press, New York, NY), pp. 63-75.
30. Salata, J.J. and J. Jalife, 1982, Effects of dantrolene sodium on the eletrophysiological properties of canine cardiac Purkinje fibers, J. Pharmacol. Exp. Ther. 220, 157.
31. Salata, J.J., J.A. Wasserstrom and J. Jalife, 1983, Dantrolene sodium. Effects on isolated cardiac tissues, J. Mol. Cell. Cardiol. 15, 233.
32. Snyder, H.R., C.S. Davis, R.K. Bickerton and R.P. Halliday, 1967, 1-[(5-Arylful-furylidene)-amino] hydantoins, J. Med. Chem. 10, 807.
33. Suarez-Isla, B.A., C. Orozco, P.F. Heller and J.P. Froehlich, 1986, Single calcium channels in native sarcoplasmic reticulum membranes from skeletal muscle, Proc. Natl. Acad. Sci. USA 83, 7741.
34. Takeshima, H., S. Nishimura, T. Matsumoto, H. Ishida, K. Kangawa, N. Minamino, H. Matsuo, M. Veda, M. Hanaoka, T. Hirose and S. Numa, 1989, Primary structure and expression from complementary DNA of skeletal muscle raynodine receptor, Nature 339, 439.
35. Thandroyen, F.T., J. McCarthy, K.P. Burton and L.H. Opie, 1988, Ryanodine and caffeine prevent ventricular arrhythmias during acute myocardial ischemia and reperfusion in rat heart, Circ. Res. 62, 306.
36. Ward, A., M.O. Caffmann and E.M. Sorkin, 1986, Dantrolene: A review of its pharmacodynamic and pharmacokinetic properties and therapeutic use in malignant hyperthermia, the neuroleptic malignant syndrome and a update of its use in muscle spasticity, Drugs 32, 130.
37. White, M.D., J.G. Collins and M.A. Denborough, 1983, The effect of dantrolene on skeletal muscle sarcoplasmic reticulum function in malignant hyperpyrexia in pigs, Biochem. J. 212, 399.
38. 2+] in mammalian ventricle and dynamic control by cellular processes, Annu. Rev. Physiol. 52, 467.
39. 2+] transient, membrane potential and contraction, J. Gen. Physiol. 83, 395.
40. 2+] by nonlinear indicators: a quantitative analysis, Biophys. J. 48, 533.